S-1 · primary offering
Issued 2024
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 52 of Camp4 Therapeutics Corp's SEC filings and found 3 warrant series, 2 convertibles, 1 ATM program, 3 shelf registrations, 1 S-1 registration and 3 completed offerings on file for CAMP. The latest dilution event on file is a registration statement on Aug 12, 2026. Analysis updated Nov 1, 2026.
Raise routes on file: active ATM + effective shelf · latest dilution event 83 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Aug 12, 2026 · Registration
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2024
Proposed maximum
Shares registered
Issued 2025
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Principal
Conversion Price
Principal
Conversion Price
Issued 2025
Total capacity
Sold to date
Issued 2025
Total capacity
Remaining
Issued 2025
Total capacity
Remaining
Issued 2026
Total capacity
Remaining
Issued 2026
Gross proceeds
Price per share
Issued 2025
Gross proceeds
Price per share
Issued 2025
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z